Radiology Partners announced Wednesday, June 27, that the research sector of its practice, Radiology Partners Research Institute (RPRI), “has seen early success in its scholarly efforts” since launching back in January.

Authors of a June 26 editorial in Annals of Internal Medicine advocated for a standard definition of "overdiagnosis" regarding cancer screenings, arguing poor understanding of the term is a threat that exposes patients to unnecessary treatments.

Women with dense breasts see higher cancer rates than their non-dense breast counterparts, suggesting additional screening might be beneficial, a nationwide study out of Norway has found.

A new study found ultra-high strength MRI may release toxic mercury from silver fillings, though commonly used 1.5 Tesla MRI machines appear to have no effect on the cavity-prone.

18F-Fluciclovine PET/CT can help detect previously undetected lesions in patients with biochemical recurrence of prostate cancer, according to a report presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2018 Annual Meeting.

In 2014, after telling his primary care physician he had noticed a small bump on his chest, Khevin Barnes was diagnosed with breast cancer. A mastectomy of his left breast followed.

Scientists have developed a novel PET radiotracer that outpaces current methods of imaging for cardiovascular bacterial infections, according to research presented at the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging in Philadelphia, Pennsylvania. 

Stella Kang, MD, MSc, was the lead author of a study that determined women who undergo breast cancer screening with mammography are much more likely to utilize other preventive services than unscreened women. She spoke to Radiology Business about the importance of that study and more.